These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

8897 related articles for article (PubMed ID: 22236355)

  • 1. Fascin-1 expression in canine cutaneous and oral melanocytic tumours.
    Yamada N; Mori T; Murakami M; Noguchi S; Sakai H; Akao Y; Maruo K
    Vet Comp Oncol; 2012 Dec; 10(4):303-11. PubMed ID: 22236355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical expression of tenascin in melanocytic tumours of dogs.
    Sevastre B; van Ederen AM; Terlou M; Gruys E; Nederbragt H
    J Comp Pathol; 2007 Jan; 136(1):49-56. PubMed ID: 17258226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C-kit expression in canine mucosal melanomas.
    Newman SJ; Jankovsky JM; Rohrbach BW; LeBlanc AK
    Vet Pathol; 2012 Sep; 49(5):760-5. PubMed ID: 21825314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of prognostic significance of angiogenesis in canine melanocytic tumours.
    Cuitiño MC; Massone AR; Idiart JR
    J Comp Pathol; 2012; 147(2-3):147-52. PubMed ID: 22520819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COX-1 and COX-2 expression in canine cutaneous, oral and ocular melanocytic tumours.
    Pires I; Garcia A; Prada J; Queiroga FL
    J Comp Pathol; 2010; 143(2-3):142-9. PubMed ID: 20207364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of monocarboxylate transporter 1 in oral and ocular canine melanocytic tumors.
    Shimoyama Y; Akihara Y; Kirat D; Iwano H; Hirayama K; Kagawa Y; Ohmachi T; Matsuda K; Okamoto M; Kadosawa T; Yokota H; Taniyama H
    Vet Pathol; 2007 Jul; 44(4):449-57. PubMed ID: 17606506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alteration in E-cadherin/β-catenin expression in canine melanotic tumors.
    Han JI; Kim Y; Kim DY; Na KJ
    Vet Pathol; 2013 Mar; 50(2):274-80. PubMed ID: 22895538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Canine melanoma diagnosis: RACK1 as a potential biological marker.
    Campagne C; Julé S; Alleaume C; Bernex F; Ezagal J; Château-Joubert S; Estrada M; Aubin-Houzelstein G; Panthier JJ; Egidy G
    Vet Pathol; 2013 Nov; 50(6):1083-90. PubMed ID: 23735618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of KIT expression and KIT exon 11 mutations in canine oral malignant melanomas.
    Murakami A; Mori T; Sakai H; Murakami M; Yanai T; Hoshino Y; Maruo K
    Vet Comp Oncol; 2011 Sep; 9(3):219-24. PubMed ID: 21848624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclooxygenase-2 expression is associated with infiltration of inflammatory cells in oral and skin canine melanomas.
    Silveira TL; Veloso ES; Gonçalves INN; Costa RF; Rodrigues MA; Cassali GD; Del Puerto HL; Pang LY; Argyle DJ; Ferreira E
    Vet Comp Oncol; 2020 Dec; 18(4):727-738. PubMed ID: 32323423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical expression of MDR1-Pgp 170 in canine cutaneous and oral melanomas: pattern of expression and association with tumour location and phenotype.
    Finotello R; Monné Rodriguez JM; Vilafranca M; Altimira J; Ramirez GA; Haines A; Ressel L
    Vet Comp Oncol; 2017 Dec; 15(4):1393-1402. PubMed ID: 27779366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered expression of versican and hyaluronan in melanocytic tumors of dogs.
    Docampo MJ; Rabanal RM; Miquel-Serra L; Hernández D; Domenzain C; Bassols A
    Am J Vet Res; 2007 Dec; 68(12):1376-85. PubMed ID: 18052744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fascin expression in melanocytic lesions of the skin.
    YILDIZ L; KEFELI M; AYDIN O; KANDEMIR B
    Eur J Dermatol; 2009; 19(5):445-50. PubMed ID: 19527987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclooxygenase-2 expression is related with localization, proliferation, and overall survival in canine melanocytic neoplasms.
    Martínez CM; Peñafiel-Verdú C; Vilafranca M; Ramírez G; Méndez-Gallego M; Buendía AJ; Sánchez J
    Vet Pathol; 2011 Nov; 48(6):1204-11. PubMed ID: 21292918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Canine balloon and signet-ring cell melanomas: a histological and immunohistochemical characterization.
    Cangul IT; van Garderen E; van der Linde-Sipman JS; van den Ingh TS; Schalken JA
    J Comp Pathol; 2001; 125(2-3):166-73. PubMed ID: 11578133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Canine cutaneous melanocytic tumours: significance of β-catenin and survivin immunohistochemical expression.
    Bongiovanni L; D'Andrea A; Porcellato I; Ciccarelli A; Malatesta D; Romanucci M; Della Salda L; Mechelli L; Brachelente C
    Vet Dermatol; 2015 Aug; 26(4):270-e59. PubMed ID: 25962968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. E-Cadherin Expression in Canine Melanocytic Tumors: Histological, Immunohistochemical, and Survival Analysis.
    Silvestri S; Porcellato I; Mechelli L; Menchetti L; Iussich S; De Maria R; Sforna M; Bongiovanni L; Brachelente C
    Vet Pathol; 2020 Sep; 57(5):608-619. PubMed ID: 32578507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of matrix metalloproteinase-2 and -9 and membrane-type 1 matrix metalloproteinase in melanocytic tumors of dogs and canine melanoma cell lines.
    Docampo MJ; Cabrera J; Rabanal RM; Bassols A
    Am J Vet Res; 2011 Aug; 72(8):1087-96. PubMed ID: 21801067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metallothionein expression in canine and feline mammary and melanotic tumours.
    Dincer Z; Jasani B; Haywood S; Mullins JE; Fuentealba IC
    J Comp Pathol; 2001; 125(2-3):130-6. PubMed ID: 11578128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diverse roles of epidermal growth factors receptors in oral and cutaneous canine melanomas.
    Veloso ES; Gonçalves INN; Silveira TL; Oliveira FS; Vieira DS; Cassali GD; Del Puerto HL; Ferreira E
    BMC Vet Res; 2020 Jan; 16(1):24. PubMed ID: 31996230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 445.